Efficacy News and Research

RSS

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

Study offers solid link between visceral organs and brain’s reward, motivation system

A novel gut-to-brain neural circuit establishes the vagus nerve as an essential component of the brain system that regulates reward and motivation, according to research conducted at the Icahn School of Medicine at Mount Sinai and published September 20 in the journal Cell.

21 Sep 2018

Experts warn health care providers to slow down in allowing smart pill in patient care settings

Enthusiasm for an emerging digital health tool, the smart pill, is on the rise but researchers at the University of Illinois at Chicago have published a paper in the American Journal of Bioethics that cautions health care providers and policymakers to slow down when it comes to allowing this technology in patient care settings.

21 Sep 2018

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

A team of researchers at the University of Cologne's Faculty of Medicine and the German Center for Infection Research has achieved a scientific breakthrough in the accelerated diagnosis of multi-resistant hospital pathogens.

20 Sep 2018

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

20 Sep 2018

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Cell Medica announces the treatment of the first patient world-wide to receive CMD-501, an autologous CAR-NKT therapy targeting pediatric neuroblastoma

20 Sep 2018

Oxehealth secures European medical device accreditation for vital signs measurement software

The British Standards Institute has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.

19 Sep 2018

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later.

19 Sep 2018

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.

19 Sep 2018

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor.

18 Sep 2018

Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule

The efficacy of chemotherapy treatment depends on how effectively it reaches cancerous cells. Increasing targeted delivery could mean decreasing side effects.

18 Sep 2018

Digital games for CVD-related self-management improve exercise capacity and energy expenditure

A scoping review of studies on game interventions for cardiovascular diseaseself-management found that the use of digital games improved exercise capacity and energy expenditure significantly.

18 Sep 2018

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

For many years amyloid β protein was considered to be a promising therapeutic target in Alzheimer's disease but, for a long time, research results were very disappointing.

18 Sep 2018

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Results from INPULSIS-ON, published today in Lancet Respiratory Medicine, provide insights into the long-term safety, efficacy, and tolerability of Ofev (nintedanib) in patients with idiopathic pulmonary fibrosis (IPF).

17 Sep 2018

Kessler Foundation joins new study to improve cognition in people with progressive MS

Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis Society of Canada and the MS Scientific ResearchFoundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS.

14 Sep 2018

Novel treatment for hairy cell leukemia approved by FDA

The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

Efficacy News and Research

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Study offers solid link between visceral organs and brain’s reward, motivation system

Experts warn health care providers to slow down in allowing smart pill in patient care settings

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Oxehealth secures European medical device accreditation for vital signs measurement software

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule

Digital games for CVD-related self-management improve exercise capacity and energy expenditure

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Kessler Foundation joins new study to improve cognition in people with progressive MS

Novel treatment for hairy cell leukemia approved by FDA

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Mitochondrial pathway found to be involved in breast cancer

Doctor to the stars disciplined over use of controversial menopause therapy

Targeting pathway controlling mitochondria may reduce cancer invasiveness

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News